Hims & Hers Health, Inc. (HIMS) financial statements (2022 and earlier)
Company profile
Business Address |
2269 CHESTNUT ST SAN FRANCISCO, CA 94123 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
SIC | 8011 - Offices and Clinics of Doctors of Medicine (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
12/31/2021 | 12/31/2020 | 12/31/2019 | |||
---|---|---|---|---|---|
ASSETS | |||||
Current Assets | |||||
Cash, cash equivalents, and short-term investments | 247,274 | 1,058 | 1,510 | ||
Cash and cash equivalents | 71,784 | 1,058 | 1,510 | ||
Short-term investments | 175,490 | ||||
Receivables | 4,100 | ||||
Inventory, net of allowances, customer advances and progress billings | 13,558 | ||||
Inventory | 13,558 | ||||
Prepaid expense | 4,606 | 50 | 148 | ||
Other current assets | 890 | ||||
Other undisclosed current assets | (523) | ||||
Total current assets: | 269,905 | 1,108 | 1,658 | ||
Noncurrent Assets | |||||
Operating lease, right-of-use asset | 5,111 | ||||
Intangible assets, net (including goodwill) | 136,771 | ||||
Goodwill | 110,881 | ||||
Intangible assets, net (excluding goodwill) | 25,890 | ||||
Assets held-in-trust | 204,525 | 203,107 | |||
Restricted cash and investments | 856 | ||||
Other noncurrent assets | 7,942 | ||||
Total noncurrent assets: | 150,680 | 204,525 | 203,107 | ||
TOTAL ASSETS: | 420,585 | 205,633 | 204,765 | ||
LIABILITIES AND EQUITY | |||||
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 31,834 | 4,238 | 497 | ||
Accounts payable | 19,640 | 48 | 18 | ||
Accrued liabilities | 12,194 | 4,190 | 479 | ||
Deferred revenue | 3,188 | ||||
Due to related parties | 599 | 428 | |||
Business combination, contingent consideration, liability | 42,834 | ||||
Other undisclosed current liabilities | 1,365 | 60 | 55 | ||
Total current liabilities: | 79,221 | 4,897 | 979 | ||
Noncurrent Liabilities | |||||
Long-term debt and lease obligation | 4,117 | ||||
Operating lease, liability | 4,117 | ||||
Liabilities, other than long-term debt | 2,628 | ||||
Other liabilities | 629 | ||||
Business combination, contingent consideration, liability | 1,999 | ||||
Other undisclosed noncurrent liabilities | 7,194 | 7,194 | |||
Total noncurrent liabilities: | 6,745 | 7,194 | 7,194 | ||
Total liabilities: | 85,966 | 12,090 | 8,173 | ||
Temporary equity, carrying amount | 188,543 | 191,592 | |||
Stockholders' equity | |||||
Stockholders' equity attributable to parent, including: | 334,619 | 5,000 | 5,000 | ||
Common stock | 20 | ||||
Additional paid in capital | 613,687 | 6,901 | 3,852 | ||
Accumulated other comprehensive loss | (137) | ||||
Retained earnings (accumulated deficit) | (278,951) | (1,902) | 1,147 | ||
Other undisclosed stockholders' equity attributable to parent | 1 | 1 | |||
Total stockholders' equity: | 334,619 | 5,000 | 5,000 | ||
TOTAL LIABILITIES AND EQUITY: | 420,585 | 205,633 | 204,765 |
Income statement (P&L) ($ in thousands)
12/31/2021 | 12/31/2020 | 12/31/2019 | ||
---|---|---|---|---|
Revenues | 271,878 | |||
Cost of revenue | (67,384) | |||
Gross profit: | 204,494 | |||
Operating expenses | (319,536) | (4,792) | ||
Operating loss: | (115,042) | (4,792) | ||
Nonoperating income | 4,247 | 1,743 | ||
Investment income, nonoperating | 3,000 | |||
Loss from continuing operations before income taxes: | (110,795) | (3,049) | ||
Income tax benefit | 3,136 | |||
Net loss available to common stockholders, diluted: | (107,659) | (3,049) |
Comprehensive Income ($ in thousands)
12/31/2021 | 12/31/2020 | 12/31/2019 | ||
---|---|---|---|---|
Net loss: | (107,659) | (3,049) | ||
Comprehensive loss: | (107,659) | (3,049) | ||
Other undisclosed comprehensive loss, net of tax, attributable to parent | (126) | |||
Comprehensive loss, net of tax, attributable to parent: | (107,785) | (3,049) |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.